Somatic mutations in MEN type 1 tumors, consistent with the Knudson "two-hit" hypothesis

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Multiple Endocrine Neoplasia type 1 (MEN1) is an autosomal dominant disorder affecting parathyroid, pituitary, and pancreatic islet cells.
• The MEN1 gene, encoding menin, is located on chromosome 11q13 and is implicated in hereditary cancer via the "two-hit" hypothesis.
• While large deletions are known second hits in MEN1, smaller intragenic mutations were previously unreported in MEN1 tumors.

Purpose of the Study:

• To investigate for intragenic somatic mutations in MEN1 tumors lacking loss of heterozygosity (LOH) at 11q13.
• To further elucidate the mechanisms of MEN1 gene inactivation in tumor development.

Main Methods:

• Analysis of six MEN1 tumors (four parathyroid, one insulinoma, one lipoma) without 11q13 LOH.
• Utilized flanking markers (D11S480, D11S1883, PYGM, D11S449, D11S913) to assess LOH.
• Sought intragenic deletions and point mutations within the MEN1 gene.

Main Results:

• Identified four somatic mutations in MEN1 tumors: two missense and two frameshift.
• These mutations were found in two parathyroid tumors, one insulinoma, and one lipoma.
• This represents the first report of small intragenic somatic mutations in MEN1-associated tumors.

Conclusions:

• The findings provide direct evidence for intragenic somatic mutations as a mechanism for MEN1 gene inactivation.
• These results reinforce the role of the MEN1 gene as a tumor suppressor, consistent with Knudson's "two-hit" hypothesis.
• Further supports the comprehensive understanding of genetic alterations in hereditary endocrine neoplasias.